Glipizide ER (extended release) is a medication used to treat type 2 diabetes. It is a sulfonylurea drug, which works by stimulating the pancreas to produce more insulin. It is a long-acting form of glipizide, which is a generic drug. Glipizide ER is a once-daily medication that helps to control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or insulin. The aim of this article is to provide a comprehensive review of glipizide ER, including its effectiveness, side effects, and safety.
Glipizide ER is an extended-release form of glipizide, a generic drug. It works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps the body use glucose from carbohydrates in the food we eat for energy or to store glucose for future use. Glipizide ER is usually taken once daily, usually in the morning. It is usually taken with food to reduce the risk of low blood sugar.
Studies have shown that glipizide ER is effective in controlling blood sugar levels in people with type 2 diabetes. In a 12-week study of over 400 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing fasting blood glucose levels. In another study of over 500 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing HbA1c levels.
Like all medications, glipizide ER can cause side effects. Common side effects include nausea, headache, dizziness, and diarrhea. Less common side effects include skin rash, weight gain, and abdominal pain. Rare side effects include low blood sugar (hypoglycemia) and an allergic reaction.
Glipizide ER is generally safe when taken as directed. It is important to follow the instructions of your healthcare provider when taking this medication. It is also important to monitor your blood sugar levels regularly and to report any changes to your healthcare provider.
In conclusion, glipizide ER is an effective medication for controlling blood sugar levels in people with type 2 diabetes. It is usually taken once daily and is usually taken with food to reduce the risk of low blood sugar. Common side effects include nausea, headache, dizziness, and diarrhea. It is important to follow the instructions of your healthcare provider and to monitor your blood sugar levels regularly.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation